128 related articles for article (PubMed ID: 1678379)
1. Clinical experience with the recently developed progestogens.
Skouby SO; Petersen KR
Int J Fertil; 1991; 36 Suppl 1():32-7. PubMed ID: 1678379
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic impact of current estrogen-progestins and cardiovascular consequences].
Gaspard U; Lambotte R
Bull Mem Acad R Med Belg; 1991; 146(8-10):334-42; discussion 342-5. PubMed ID: 1815814
[TBL] [Abstract][Full Text] [Related]
3. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives on combination oral contraceptives.
Smith MA; Youngkin EQ
Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
[TBL] [Abstract][Full Text] [Related]
5. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptives.
Shearman RP
Aust Fam Physician; 1984 Sep; 13(9):685-91. PubMed ID: 6508652
[TBL] [Abstract][Full Text] [Related]
7. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
9. Desogestrel, norgestimate, and gestodene: the newer progestins.
Kaplan B
Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
[TBL] [Abstract][Full Text] [Related]
10. [Metrorrhagia caused by estrogen-progestin combinations].
Erny R; Erny N
Contracept Fertil Sex (Paris); 1994 Feb; 22(2):93-7. PubMed ID: 12319056
[TBL] [Abstract][Full Text] [Related]
11. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives and lipoprotein metabolism.
Tikkanen MJ; Nikkilä EA
J Reprod Med; 1986 Sep; 31(9 Suppl):898-905. PubMed ID: 3772909
[TBL] [Abstract][Full Text] [Related]
13. The triphasics: insights for effective clinical use.
Youngkin EQ; Miller LG
Nurse Pract; 1987 Feb; 12(2):17-8, 23, 26-8. PubMed ID: 3822267
[TBL] [Abstract][Full Text] [Related]
14. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
Gaspard U; Dubois M
Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives in 1984.
Chapler EK
Iowa Med; 1984 Oct; 74(10):439-40, 442. PubMed ID: 6490338
[TBL] [Abstract][Full Text] [Related]
16. The new pills: awaiting the next generation of oral contraceptives.
Klitsch M
Fam Plann Perspect; 1992; 24(5):226-8. PubMed ID: 1426186
[TBL] [Abstract][Full Text] [Related]
17. [How to choose an oral contraceptive in 1984].
Rozenbaum H
Contracept Fertil Sex (Paris); 1984 Nov; 12(11):1201-6. PubMed ID: 12266609
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases].
Kuhl H
Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):653-62. PubMed ID: 1452000
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of biphasic and triphasic pills.
Cohen J
IPPF Med Bull; 1985 Aug; 19(4):1-2. PubMed ID: 12280230
[TBL] [Abstract][Full Text] [Related]
20. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
